| Company Name | Exchange | Ticker | Last Price | Day 1 (% Change) | Day 2 (% Change) | 52 WEEK HIGH | 52 WEEK LOW | Last Volume | M.Cap MM ($) |
| Ariad Pharmaceuticals Inc | NASDAQ | ARIA | 8.99 | 12.1% | 19.5% | 23.00 | 2.15 | 134,477,591 | 1,669.0 |
A U.S healthcare stock is featured as today’s top stock to watch based
on its performance during the previous trading session. These stock recorded
a strong price gain momentum during the past two trading session with significant
volumes.
Ariad Pharmaceuticals Inc (NASDAQ: ARIA), a global oncology company focused
on the discovery, development and commercialization of medicines for the
cancer patients, gained over 34% during its past two trading sessions gaining
more than 12% in each of the two consecutive days. During its last trading
session, the stock gained 19.5% and closed at $8.99 with significant trading
volume of 134.5 million shares. During its past 5-trading sessions, ARIA
gained 33.4% with 5-day average volume of 51.47 million shares compared
to 1-month daily average volume of 34.6 million shares. On January 24,
2014, BMO Capital upgraded ARIA to outperform rating from market perform
with a price target of $14 from $8. Analyst foresees a significant value
in the company’s assets and believes that it will attract interest from
large pharmaceutical companies.
